Endo International PLC (ENDP)

11.37
NASDAQ : Health Care
Prev Close 11.28
Day Low/High 11.19 / 11.64
52 Wk Low/High 9.70 / 28.67
Avg Volume 8.89M
Exchange NASDAQ
Shares Outstanding 222.96M
Market Cap 2.51B
EPS -15.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Movers: Organovo, Endo, Omeros

Biotech Movers: Organovo, Endo, Omeros

Organovo, Endo and Omeros were among the biotech stock moves in premarket trading on Thursday.

Biotech Movers: Ultragenyx Jumps on Phase Three Burosumab Data

Biotech Movers: Ultragenyx Jumps on Phase Three Burosumab Data

Ultragenyx, together with Kyowa Hakko Kirin and Kyowa Kirin International, on Tuesday unveiled 24-week data from a phase three study of burosumab in adults.

Endo international, AngioDynamics Lead Biotech Movers

Endo international, AngioDynamics Lead Biotech Movers

Endo International slipped 5% ahead of market's open Friday.

FDA deals blow to Endo over Opana ER Pain Med

FDA deals blow to Endo over Opana ER Pain Med

An FDA advisory committee has found that risks of Endo International's pain drug Opana ER now overshadow the drug's benefits.

Welcome to the Small-Cap Biotech Mailbag!

Welcome to the Small-Cap Biotech Mailbag!

We answer recent reader questions about three of the biotech stocks we regularly cover.

Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo

Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo

Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.

Cramer: Reviewing S&P's Hit-and-Miss Parade

Cramer: Reviewing S&P's Hit-and-Miss Parade

Even among the losers, buys are scarce.

ENDP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Endo International Plc And A Lead Plaintiff Deadline Of January 6, 2017

ENDP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Endo International Plc And A Lead Plaintiff Deadline Of January 6, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Endo International plc (NASDAQ:ENDP) securities...

3 Troubled Companies and How to Play Them in the New Year

3 Troubled Companies and How to Play Them in the New Year

The share prices of Mylan, Sears and Endo International fell dramatically in 2016, and the companies face significant challenges ahead.

Make Sure Your Portfolio Is Protected From Volatility

Make Sure Your Portfolio Is Protected From Volatility

If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.

Endo International Is Top 'Dog of the S&P 500'

Endo International Is Top 'Dog of the S&P 500'

There are more dogs on the S&P 500 than on the Dow. Here's one example.

GPM Reminds Investors Of The January 6th Deadline In The Class Action Lawsuit Against Endo International Plc And Encourages Investors To Contact The Firm

GPM Reminds Investors Of The January 6th Deadline In The Class Action Lawsuit Against Endo International Plc And Encourages Investors To Contact The Firm

Glancy Prongay & Murray LLP ("GPM") reminds investors of the January 6, 2017 deadline to file a lead plaintiff motion in the class action lawsuit filed on behalf of investors who purchased or otherwise acquired...

Impax Searches for a New CEO

Impax Searches for a New CEO

Impax Laboratories CEO G. Frederick Wilkinson steps down amid a Department of Justice generic price-fixing investigation. J. Kevin Buchi, who joined the board last month, was tapped as interim CEO.

DOJ Files Charges in Generic Drug Price-Fixing Investigation

DOJ Files Charges in Generic Drug Price-Fixing Investigation

Shares of leading generics fall as more charges are expected.